These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 14270667)

  • 1. [EXPERIMENTAL STUDIES ON THE EFFECT OF SO-CALLED SECONDARY ANTITUBERCULOSIS DRUGS. (1). COMBINATION EFFECTS OF SM-INH-PAS, SM-INH-TH AND KM-TH-CS ON EXPERIMENTAL TUBERCULOSIS IN MICE].
    TAGA M
    Kekkaku; 1964 Dec; 39():543-9. PubMed ID: 14270667
    [No Abstract]   [Full Text] [Related]  

  • 2. ACTIVITY OF ANTITUBERCULOSIS DRUGS AGAINST MYCOBACTERIUM LEPRAE.
    SHEPARD CC; CHANG YT
    Int J Lepr; 1964; 32():260-71. PubMed ID: 14227399
    [No Abstract]   [Full Text] [Related]  

  • 3. [ACTION ON MYCOBACTERIUM TUBERCULOSIS OF CAPREOMYCIN IN VITRO, ALONE OR COMBINED WITH STREPTOMYCIN, INH (ISONICOTINIC HYDRAZIDE) OR PAS (PARA-AMINOSALICYLIC ACID)].
    COLETSOS P
    C R Hebd Seances Acad Sci; 1964 Apr; 258():3936-7. PubMed ID: 14145409
    [No Abstract]   [Full Text] [Related]  

  • 4. [ACTION OF CAPREOMYCIN ON MYCOBACTERIUM TUBERCULOSIS IN FLUID CULTURE MEDIA ALONE OR ASSOCIATED WITH STREPTOMYCIN, INH AND PAS].
    COLETSOS PJ; ORIOT E
    Ann Inst Pasteur (Paris); 1964 Aug; 107():215-31. PubMed ID: 14196629
    [No Abstract]   [Full Text] [Related]  

  • 5. [CHEMO-ANTIBIOTIC THERAPY OF TUBERCULOSIS IN DIABETICS AND ITS REPERCUSSIONS ON GLUCIDE METABOLISM].
    FILLA E; COMENALE D; ROSSI F
    Minerva Med; 1964 Aug; 55():2417-22. PubMed ID: 14192139
    [No Abstract]   [Full Text] [Related]  

  • 6. [RECURRENCE FOLLOWING CONSERVATIVE THERAPEUTIC PROCEDURES FOR BACILLARY PULMONARY TUBERCULOSIS IN ELDERLY PATIENTS].
    MUELLER F
    Z Tuberk Erkr Thoraxorg; 1963 Jul; 120():172-5. PubMed ID: 14049311
    [No Abstract]   [Full Text] [Related]  

  • 7. [EFFECTS OF ETHIONAMIDE ON TUBERCLE BACILLI RESISTANT TO VARIOUS ANTITUBERCULAR AGENTS AND THE EFFECTS OF THESE AGENTS ON ETHIONAMIDE-RESISTANT TUBERCLE BACILLI].
    TSUCHIMOCHI T
    Kekkaku; 1963 Jun; 38():264-9. PubMed ID: 14046673
    [No Abstract]   [Full Text] [Related]  

  • 8. [STUDY ON BCG STRAIN VARIANTS RESISTANT TO STREPTOMYCIN, INH AND PAS. II. VACCINANT PROPERTIES IN THE ABSENCE OR PRESENCE OF A TREATMENT WITH THE HOMOLOGOUS TUBERCULOSTATIC].
    BOTEZ V; PARASCHIVESCO M; GHEORGHIU M; ANGELESCO I; BONCIU C; PETROVICI M
    Arch Roum Pathol Exp Microbiol; 1963; 22():951-60. PubMed ID: 14170981
    [No Abstract]   [Full Text] [Related]  

  • 9. [The choice of drug to be combined with INH in the initial drug therapy of tuberculosis patients].
    BOSZORMENYI M; FAUSZT I; BARABAS M; BARAT I; JAKAB Z; MAJZIK G; SCHWEIGER O
    Tuberkulozis; 1962 Dec; 15():360-4. PubMed ID: 14014238
    [No Abstract]   [Full Text] [Related]  

  • 10. [ON CASES OF HIGHLY VIRULENT AND NORMALLY VIRULENT BOVINE PULMONARY TUBERCULOSIS].
    OTTO H
    Z Arztl Fortbild (Jena); 1964 Feb; 58():165-71. PubMed ID: 14151721
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental tuberculous meningitis in guinea pigs. 3. The effect of the administration of SM or INH alone and of SM. INH and PAS in combination].
    TAKAHASHI H
    Kekkaku; 1959 Sep; 34():607-13. PubMed ID: 13836636
    [No Abstract]   [Full Text] [Related]  

  • 12. [THE COMBINATION INH AND ISONICOTINYLADEHYDE-THIOSEMICARBAZONE IN THE TREATMENT OF TUBERCULOSIS IN CHILDHOOD].
    SILVEIRA J; MEDEIROS S
    Hospital (Rio J); 1963 Sep; 64():561-86. PubMed ID: 14112139
    [No Abstract]   [Full Text] [Related]  

  • 13. [CHEMICAL COMPOSITION OF THE STRAIN MYCOBACTERIUM TUBERCULOSIS VAR. BOVIS--BCG AND ITS VARIANTS RESISTANT TO STREPTOMYCIN, INH AND PAS].
    PODHORSKY E; BOTEZ V; PARASCHIVESCO M; GHEORGHIU M
    Arch Roum Pathol Exp Microbiol; 1963 Sep; 23():623-30. PubMed ID: 14165839
    [No Abstract]   [Full Text] [Related]  

  • 14. [SYMPOSIUM: COUNTER-MEASURES IN INTRACTABLE PULMONARY TUBERCULOSIS].
    KITAMOTO O
    Kekkaku; 1963 Aug; 38():348-71. PubMed ID: 14046681
    [No Abstract]   [Full Text] [Related]  

  • 15. [ANTITUBERCULAR ALKYLMERCAPTOETHYLUREAS AND THIOSEMICARBAZIDES].
    BABUDIERI B; PORCELLI GA; STEIN ML; ZARDI O
    Farmaco Sci; 1964 Jun; 19():537-42. PubMed ID: 14174307
    [No Abstract]   [Full Text] [Related]  

  • 16. CHEMOTHERAPY OF TUBERCULOSIS: A BACTERIOLOGIST'S VIEWPOINT.
    MITCHISON DA
    Br Med J; 1965 May; 1(5446):1333-40. PubMed ID: 14278838
    [No Abstract]   [Full Text] [Related]  

  • 17. [DRUG TREATMENT OF RENAL TUBERCULOSIS].
    TUOVINEN PI; SUTINEN S
    Suom Laakaril; 1964 Aug; 19():1629-38. PubMed ID: 14179990
    [No Abstract]   [Full Text] [Related]  

  • 18. [UROGENITAL TUBERCULOSIS: PATHOGENESIS, DIAGNOSIS AND THERAPY. SURVEY OF THE MOST IMPORTANT PUBLICATIONS OF THE LAST YEARS].
    ALBRECHT KF
    Urologe; 1964 Jan; 3():33-7. PubMed ID: 14160920
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of tuberculosis on a combined regimen of x-ray and anti-tuberculous drugs. Report 2. An animal experiment as to the effectiveness of a combined regimen of x-ray, streptomycin (SM), isonicotinic acid hydrazide (INH) and/or para-aminosalicylic acid (PAS)].
    FUKUI A
    Kekkaku; 1959 Dec; 34():851-6. PubMed ID: 13825600
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytogenetic effects of chemotherapy with three combinations of anti-tubercular drugs involving isoniazid, thiacetazone, para-aminosalicylic acid and streptomycin on human lymphocytes: chromosome aberrations, sister chromatid exchanges and mitotic index.
    Jaju M; Jaju M; Ahuja YR
    Hum Genet; 1983; 64(1):42-9. PubMed ID: 6192073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.